ERBB2 and breast carcinoma: Our data also reveal some unanticipated results, such as the high level of ecDNA found in HER2+ breast cancer (39.3–53.7%), including amplification of ERBB2 on ecDNA in 26% of HER2+ breast cancers (Supplementary Table 2).